Eckert & Ziegler SE (BIT:1EUZ)

Italy flag Italy · Delayed Price · Currency is EUR
66.20
+3.00 (4.75%)
Last updated: Jul 21, 2025
4.75%
Market Cap1.35B
Revenue (ttm)296.43M
Net Income (ttm)34.48M
Shares Outn/a
EPS (ttm)1.63
PE Ratio39.12
Forward PE24.43
Dividend0.50 (0.79%)
Ex-Dividend DateJun 19, 2025
Volume16
Average Volume1
Open63.90
Previous Close63.20
Day's Range63.90 - 66.20
52-Week Range37.43 - 66.25
Betan/a
RSI83.45
Earnings DateAug 8, 2025

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynt... [Read more]

Industry Industrial Inorganic Chemicals
Founded 2024
Employees 1,085
Stock Exchange Borsa Italiana
Ticker Symbol 1EUZ
Full Company Profile

Financial Performance

In 2024, Eckert & Ziegler SE's revenue was 295.85 million, an increase of 20.22% compared to the previous year's 246.09 million. Earnings were 33.28 million, an increase of 26.52%.

Financial Statements

News

There is no news available yet.